These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 2032444

  • 1. Neutropenia in patients infected with human immunodeficiency virus.
    Israel DS, Plaisance KI.
    Clin Pharm; 1991 Apr; 10(4):268-79. PubMed ID: 2032444
    [Abstract] [Full Text] [Related]

  • 2. Granulocyte-macrophage colony-stimulating factor and zidovudine in the treatment of neutropenia and human immunodeficiency virus infection.
    Hewitt RG, Morse GD.
    Pharmacotherapy; 1992 Apr; 12(6):455-61. PubMed ID: 1492010
    [Abstract] [Full Text] [Related]

  • 3. A randomized controlled trial of a protease inhibitor (saquinavir) in combination with zidovudine in previously untreated patients with advanced HIV infection.
    Vella S, Lazzarin A, Carosi G, Sinicco A, Armignacco O, Angarano G, Andreoni M, Tambussi G, Chiodera A, Floridia M, Scaccabarozzi S, Facey K, Duncan I, Boudes P, Bragman K.
    Antivir Ther; 1996 Aug; 1(3):129-40. PubMed ID: 11322246
    [Abstract] [Full Text] [Related]

  • 4. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [Abstract] [Full Text] [Related]

  • 5. Effects of vitamins, including vitamin A, on HIV/AIDS patients.
    Mehta S, Fawzi W.
    Vitam Horm; 2007 Nov; 75():355-83. PubMed ID: 17368322
    [Abstract] [Full Text] [Related]

  • 6. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [Abstract] [Full Text] [Related]

  • 7. [Rapid development of anemia in a HIV-positive patient with alpha-thalassemia after zidovudine therapy].
    Altinbaş A, Ozkaya G, Büyükaşik Y, Unal S.
    Mikrobiyol Bul; 2007 Jul; 41(3):473-6. PubMed ID: 17933262
    [Abstract] [Full Text] [Related]

  • 8. Zidovudine monotherapy versus zidovudine plus zalcitabine combination therapy in HIV-positive persons with CD4 cell counts 300-500 cells/mm3: a double-blind controlled trial. The M50003 Study Group Coordinating and Writing Committee.
    Moyle GJ, Bouza E, Antunes F, Smith D, Harris R, Warburg M, Walker M.
    Antivir Ther; 1997 Dec; 2(4):229-36. PubMed ID: 11327442
    [Abstract] [Full Text] [Related]

  • 9. Neutropenia, neutrophil dysfunction, and bacterial infection in patients with human immunodeficiency virus disease: the role of granulocyte colony-stimulating factor.
    Kuritzkes DR.
    Clin Infect Dis; 2000 Feb; 30(2):256-60. PubMed ID: 10671324
    [Abstract] [Full Text] [Related]

  • 10. Human immunodeficiency virus and acquired immunodeficiency syndrome: an update.
    Schnittman SM, Fauci AS.
    Adv Intern Med; 1994 Feb; 39():305-55. PubMed ID: 8140958
    [Abstract] [Full Text] [Related]

  • 11. Synergistic inhibition of AZT-resistant HIV by AZT combined with poly(I):poly(C12U), without synergistic toxicity to bone marrow progenitor cell elements.
    Gillespie D, Hubbell HR, Carter WA, Midgette P, Elsasser W, Mullaney R, Strayer DR.
    In Vivo; 1994 Feb; 8(3):375-81. PubMed ID: 7803722
    [Abstract] [Full Text] [Related]

  • 12. [Neutropenia in HIV infection].
    Moreno García M.
    An Med Interna; 1997 Apr; 14(4):199-208. PubMed ID: 9181819
    [Abstract] [Full Text] [Related]

  • 13. Blunted humoral response to influenza vaccination in patients exposed to zidovudine plus trimethoprim-sulfamethoxazole.
    Feola DJ, Garvy BA, Rapp RP, Thornton AC.
    Pharmacotherapy; 2007 Jul; 27(7):937-47. PubMed ID: 17594199
    [Abstract] [Full Text] [Related]

  • 14. Etiology and natural history of neutropenia in human immunodeficiency virus disease: a prospective study.
    Moore DA, Benepal T, Portsmouth S, Gill J, Gazzard BG.
    Clin Infect Dis; 2001 Feb 01; 32(3):469-75. PubMed ID: 11170956
    [Abstract] [Full Text] [Related]

  • 15. Zidovudine (Retrovir) update.
    Rachlis AR.
    CMAJ; 1990 Dec 01; 143(11):1177-85. PubMed ID: 2224694
    [Abstract] [Full Text] [Related]

  • 16. Open-label phase I study of combination therapy with zidovudine and interferon-beta in patients with AIDS-related Kaposi's sarcoma: AIDS Clinical Trials Group Protocol 057.
    Miles S, Levine A, Feldstein M, Carden J, Cabriallas S, Marcus S, Mitsuyasu R, Gill P.
    Cytokines Cell Mol Ther; 1998 Mar 01; 4(1):17-23. PubMed ID: 9557213
    [Abstract] [Full Text] [Related]

  • 17. Current strategies for managing myelosuppression in patients with cancer.
    Rostad ME.
    Oncol Nurs Forum; 1991 Mar 01; 18(2 Suppl):7-15. PubMed ID: 1904577
    [Abstract] [Full Text] [Related]

  • 18. Study of the role of vitamin B12 and folinic acid supplementation in preventing hematologic toxicity of zidovudine.
    Falguera M, Perez-Mur J, Puig T, Cao G.
    Eur J Haematol; 1995 Aug 01; 55(2):97-102. PubMed ID: 7628595
    [Abstract] [Full Text] [Related]

  • 19. Etiology of neutropenia in HIV-infected patients.
    Jaresko GS.
    Am J Health Syst Pharm; 1999 Dec 15; 56 Suppl 5():S5-8. PubMed ID: 10613380
    [Abstract] [Full Text] [Related]

  • 20. Transfusion in HIV disease.
    Sloand EM, Groopman JE.
    Curr Opin Hematol; 1997 Nov 15; 4(6):449-54. PubMed ID: 9359004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.